DR. WADDAH AL-REFAIE

MDReal-Time Hydrated
Practice Location: WASHINGTON, DC 20007
NPI Number: 1801825237
LIFETIME INDUSTRY VALUE
$986
2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AL-REFAIE is a verified Surgery, Surgical Oncology practitioner based in WASHINGTON, DC.

Between 2021 and 2025, Dr. AL-REFAIE had an overall industry promotional and research financial footprint of $986 as recorded in the federal CMS Open Payments database.

  • $986 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
  • $0 was allocated to sponsored clinical trials and medical research activities.

Dr. AL-REFAIE's primary funding source is INTEGRA LIFESCIENCES CORPORATION, which accounts for $579 (representing 58.7% of overall industry footprint).

Data coverage: 2021 – 2025  ·  Source: CMS Open Payments  ·  CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments
Research Funding
$627$314$0$282021$02022$6272023$1392024$1912025

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

INTEGRA LIFESCIENCES CORPORATION
Rank 1
$579
58.7%
SMITH+NEPHEW
Rank 2
$112
11.4%
HOLOGIC SALES AND SERVICE
Rank 3
$96
9.7%

General payments include consulting honoraria, promotional speaking fees, meals, travel, educational materials, and entertainment offsets.

PROMOTIONAL COUNT
Active
ESTIMATED COMPLIANCE RISK
Standard

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:
2025
2025
2024
2023
2022
2021
Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.